ARTICLE | Distillery Therapeutics
Therapeutics: Tyrosine kinase non-receptor 2 (Tnk2; ACK1)
March 5, 2015 8:00 AM UTC
In vitro studies have identified an aminopyrimidine ACK1 inhibitor that could help treat cancer. In the human prostate cancer cell line LNCaP and the highly metastatic prostate cancer cell line VCaP, ...